| Ad-Hoc | General & Press | UPDATE AlsterResearch: Target price raised to €11.30

The study on the Geratherm Group published by AlsterResearch on July 21, 2022 and the determined price target of EUR 11.00 have now been raised to EUR 11.30 following an update on 09/21/2022. The main…

Read more
| General & Press | Geratherm Respiratory at ERS Congress in Barcelona

From September 4th to 6th, 2022, Geratherm Respiratory will be exhibiting our products for lung function diagnostics at the international congress of the ERS (European Respiratory Society) in…

Read more
| Ad-Hoc | General & Press | Research study of Geratherm Medical by AlsterResearch

Geratal, 07/21/2022. Entitled “A fresh start in a new segment – ​​Initiate with BUY” AlsterResearch published their study about the Geratherm Group today. Geratherm Medical is assessed by…

Read more
| General & Press | Arab Health 2022 in Dubai, a success for Geratherm

From January 17th to 20th, the most important medical technology trade fair for the Middle East, Arab Health, took place in Dubai.

The trade fair stand of the Geratherm Group, which was represented…

Read more
| General & Press | Arab Health | January 24-27, 2022

The Geratherm Group will also be represented at the largest global healthcare event of Arab Health in Dubai in 2022 and will present its products to an international audience. The focus this year is…

Read more
| General & Press | Resignation

Mr. Rudolf Bröcker, Chairman of the Supervisory Board of Geratherm Medical AG, has informed us that he will step back from his position on the Supervisory Board at the end of the Annual General…

Read more
| General & Press | Largest single order to date for Geratherm Respiratory

The B·A·D Group, one of the largest international providers of occupational health care, orders 500 Geratherm lung function devices of the new Spirostik Blue model.

This individual order has a volume…

Read more